Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-86022Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-243313Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-290248Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-300011Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-339427Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-347748Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-358486Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-403996Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-404782Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-412255Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-413932Peak area normalizedfemale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-416201Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-424849Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-435041Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-451448Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-452116Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-467564Peak area normalizedfemale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-469803Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-479883Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-486272Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-487070Peak area normalizedmale Diabetic no neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-491157Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-514578Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-536632Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-708696Peak area normalizedmale Diabetic Neuropathy
Reversed phase NEGATIVE ION MODEPHENYLALANINE (M-H)-734626Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+20037Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+25993Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+27653Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+32866Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+37464Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+41386Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+42626Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+42629Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+42817Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+44960Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+47281Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+49428Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+54603Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+64981Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+66690Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+67809Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+83380Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+87649Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+96519Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+116587Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+493731Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+501824Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+502099Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+524520Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+606838Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEPHENYLALANINE (M+H)+705942Peak area normalizedmale Normoglycemic Neuropathy

Return to search page
  logo